Raymond James & Associates Collegium Pharmaceutical, Inc Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Raymond James & Associates holds 24,913 shares of COLL stock, worth $746,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,913
Previous 24,214
2.89%
Holding current value
$746,393
Previous $779,000
23.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
38.6MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$174 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$79 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$77.6 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$70.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.75MShares$52.3 Million0.04% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...